Treatment approaches to symptoms associated with frontotemporal degeneration

被引：22

作者：

Chow T.W. ^{[1
]}

机构：

[1] The Rotman Research Institute, Toronto, Ont. M6A 2E1

来源：

Current Psychiatry Reports | 2005年 / 7卷 / 5期

关键词：

Paroxetine; Memantine; Selegiline; Trazodone; Rivastigmine;

D O I：

10.1007/s11920-005-0040-5

中图分类号：

学科分类号：

摘要：

A systematic review of the literature reveals few randomized, controlled trials for drug therapy in frontotemporal degeneration (FTD). Although there is evidence to support a serotonergic deficit, and clinicians frequently prescribe selective serotonin reuptake inhibitors to patients with FTD, only paroxetine and trazodone have been studied. There is Class II evidence for use of rivastigmine in FTD behavioral disturbances, although there is no consistent evidence of cholinergic deficit in this illness. Copyright © 2005 by Current Science Inc.

引用

页码：376 / 380

页数：4

共 47 条

[1]

McKhann G.M., Albert M.S., Grossman M., Et al., Clinical and pathological diagnosis of frontotemporal dementia, Arch. Neurol., 58, pp. 1803-1809, (2001)

[2]

Munoz D.G., Dickson D.W., Bergeron C., Et al., The neuropathology and biochemistry of frontotemporal dementia, Ann. Neurol., 54, (2003)

[3]

Feldman H., Levy A.R., Hsiung G.Y., Et al., A Canadian cohort study of cognitive impairment and related dementias (ACCORD): Study methods and baseline results, Neuroepidemiology, 22, pp. 265-274, (2003)

[4]

Neary D., Snowden J.S., Gustafson L., Et al., Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria, Neurology, 51, pp. 1546-1554, (1998)

[5]

Brun A., Frontal lobe degeneration of non-Alzheimer type I neuropathology, Arch. Gerontol. Geriatr., 6, pp. 193-208, (1987)

[6]

Starkstein S.E., Petracca G., Chemerinski E., Kremer J., Syndromic validity of apathy in Alzheimer's disease, Am. J. Psychiatry, 158, pp. 872-877, (2001)

[7]

Thomas P., Clement J.P., Hazif-Thomas C., Leger J.M., Family, Alzheimer's disease and negative symptoms, Int. J. Geriatr. Psychiatry, 16, pp. 192-202, (2001)

[8]

Stout J.C., Wyman M.F., Johnson S.A., Et al., Frontal behavioral syndromes and functional status in probable Alzheimer disease, Am. J. Geriatr. Psychiatry, 11, pp. 386-683, (2003)

[9]

Freels S., Cohen D., Eisdorfer C., Et al., Functional status and clinical findings in patients with Alzheimer's disease, J. Gerontol., 47, (1992)

[10]

Doody R.S., Massman P., Mahurin R., Law S., Positive and negative neuropsychiatric features in Alzheimer's disease, J. Neuropsychiatry Clin. Neurosci., 7, pp. 54-60, (1995)

← 1 2 3 4 5 →